Learn More
CD55 Monoclonal Antibody (67 (N-L063)), PE, Invitrogen™
Mouse Monoclonal Antibody
3550.00 SEK - 11060.00 SEK
Specifications
Antigen | CD55 |
---|---|
Clone | 67 (N-L063) |
Applications | Flow Cytometry |
Classification | Monoclonal |
Conjugate | PE |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
10632394
|
Invitrogen
MHCD5504 |
500 ÎĽL |
3550.00 SEK
Each |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
10068192
|
Invitrogen
MHCD5504-4 |
2 mL |
11060.00 SEK
Each |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
R-phycoerythrin (PE) is a stable and highly soluble phycobiliprotein which provides maximal absorbance and fluorescence without susceptibility to internal or external fluorescence quenching, thus providing an exceptional quantum yields and molar extinction coefficients.
CD55 Monoclonal antibody specifically detects CD55 in Human samples. It is validated for Flow Cytometry.Specifications
CD55 | |
Flow Cytometry | |
PE | |
Mouse | |
PBS with 4mg/mL BSA, sucrose and 0.1% sodium azide | |
CD55; CD55 antigen; CD55 molecule (Cromer blood group); CD55 molecule, decay accelerating factor for complement; CD55 molecule, decay accelerating factor for complement (Cromer blood group); Cd55a; Complement decay-accelerating factor; complement decay-accelerating factor, GPI-anchored; complement-glycosylphosphatidylinositol; CR; CROM; Cromer blood group; Daf; Daf1; DAF-GPI; decay accelarating factor 1; decay accelerating factor 1; decay accelerating factor GPI-form; decay-accelarating factor; glycosylphophatidylinositol-anchored form; GPI anchor addition signal; GPI-DAF; RP11-357P18.1; TC | |
CD55 | |
IgG1 | |
purified | |
Antibody |
67 (N-L063) | |
Monoclonal | |
Liquid | |
Human | |
P08174 | |
1604 | |
Human CD55 | |
Primary | |
4° C, store in dark | |
CD55 |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.